SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-054153
Filing Date
2024-06-20
Accepted
2024-06-20 13:14:35
Documents
18
Period of Report
2024-06-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0208158-8k425_redwoods.htm   iXBRL 8-K 43284
2 AUDITED FINANCIAL STATEMENTS OF ANEW MEDICAL, INC. FOR THE FISCAL YEARS ENDED DE ea020815801ex99-1_redwoods.htm EX-99.1 294987
3 UNAUDITED FINANCIAL STATEMENTS OF ANEW MEDICAL, INC. FOR THE QUARTERLY PERIOD EN ea020815801ex99-2_redwoods.htm EX-99.2 327837
4 GRAPHIC ex99-1_001.jpg GRAPHIC 18292
5 GRAPHIC ex99-1_002.jpg GRAPHIC 12686
  Complete submission text file 0001213900-24-054153.txt   1013351

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rwod-20240620.xsd EX-101.SCH 3685
7 XBRL DEFINITION FILE rwod-20240620_def.xml EX-101.DEF 27225
8 XBRL LABEL FILE rwod-20240620_lab.xml EX-101.LAB 37384
9 XBRL PRESENTATION FILE rwod-20240620_pre.xml EX-101.PRE 25841
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0208158-8k425_redwoods_htm.xml XML 7323
Mailing Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010
Business Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010 646-916-5315
Redwoods Acquisition Corp. (Filer) CIK: 0001907223 (see all company filings)

IRS No.: 862727441 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41340 | Film No.: 241055243
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)